210 related articles for article (PubMed ID: 11850224)
1. Regulation of aromatase by nuclear receptors.
Yanase T; Mu YM; Nishi Y; Goto K; Nomura M; Okabe T; Takayanagi R; Nawata H
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):187-92. PubMed ID: 11850224
[TBL] [Abstract][Full Text] [Related]
2. A nuclear receptor system constituted by RAR and RXR induces aromatase activity in MCF-7 human breast cancer cells.
Mu YM; Yanase T; Nishi Y; Hirase N; Goto K; Takayanagi R; Nawata H
Mol Cell Endocrinol; 2000 Aug; 166(2):137-45. PubMed ID: 10996432
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment with specific ligands for PPARgamma:RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells.
Mu YM; Yanase T; Nishi Y; Takayanagi R; Goto K; Nawata H
Mol Cell Endocrinol; 2001 Jul; 181(1-2):239-48. PubMed ID: 11476957
[TBL] [Abstract][Full Text] [Related]
4. Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells.
Mu YM; Yanase T; Nishi Y; Waseda N; Oda T; Tanaka A; Takayanagi R; Nawata H
Biochem Biophys Res Commun; 2000 May; 271(3):710-3. PubMed ID: 10814527
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle.
Cha BS; Ciaraldi TP; Carter L; Nikoulina SE; Mudaliar S; Mukherjee R; Paterniti JR; Henry RR
Diabetologia; 2001 Apr; 44(4):444-52. PubMed ID: 11357475
[TBL] [Abstract][Full Text] [Related]
6. Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose.
Rubin GL; Duong JH; Clyne CD; Speed CJ; Murata Y; Gong C; Simpson ER
Endocrinology; 2002 Aug; 143(8):2863-71. PubMed ID: 12130549
[TBL] [Abstract][Full Text] [Related]
7. Activation of peroxisome proliferator-activated receptor-gamma and retinoid X receptor inhibits aromatase transcription via nuclear factor-kappaB.
Fan W; Yanase T; Morinaga H; Mu YM; Nomura M; Okabe T; Goto K; Harada N; Nawata H
Endocrinology; 2005 Jan; 146(1):85-92. PubMed ID: 15459115
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a region upstream of exon I.1 of the human CYP19 (aromatase) gene that mediates regulation by retinoids in human choriocarcinoma cells.
Sun T; Zhao Y; Mangelsdorf DJ; Simpson ER
Endocrinology; 1998 Apr; 139(4):1684-91. PubMed ID: 9528950
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
11. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
Mehta RG; Williamson E; Patel MK; Koeffler HP
J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
[TBL] [Abstract][Full Text] [Related]
12. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
13. The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo.
Cesario RM; Klausing K; Razzaghi H; Crombie D; Rungta D; Heyman RA; Lala DS
Mol Endocrinol; 2001 Aug; 15(8):1360-9. PubMed ID: 11463859
[TBL] [Abstract][Full Text] [Related]
14. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
[TBL] [Abstract][Full Text] [Related]
15. Retinoid X receptor (RXR) ligands activate the human 25-hydroxyvitamin D3-24-hydroxylase promoter via RXR heterodimer binding to two vitamin D-responsive elements and elicit additive effects with 1,25-dihydroxyvitamin D3.
Zou A; Elgort MG; Allegretto EA
J Biol Chem; 1997 Jul; 272(30):19027-34. PubMed ID: 9228086
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
[TBL] [Abstract][Full Text] [Related]
17. Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor.
Vu-Dac N; Schoonjans K; Kosykh V; Dallongeville J; Heyman RA; Staels B; Auwerx J
Mol Cell Biol; 1996 Jul; 16(7):3350-60. PubMed ID: 8668150
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinedione induces apoptosis and monocytic differentiation in the promyelocytic leukemia cell line HL60.
Hirase N; Yanase T; Mu Y; Muta K; Umemura T; Takayanagi R; Nawata H
Oncology; 1999 Oct; 57 Suppl 2():17-26. PubMed ID: 10545799
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of a fibroblast growth factor-binding protein by receptor-selective analogs of retinoic acid.
Boyle BJ; Harris VK; Liaudet-Coopman ED; Riegel AT; Wellstein A
Biochem Pharmacol; 2000 Dec; 60(11):1677-84. PubMed ID: 11077050
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
